Evofem Biosciences reports $20.2 million net sales in 2025
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Evofem Reports Fifth Consecutive Year of Net Sales Growth
March 11, 2026 4:05 PM EDTNet sales surpassed $20 million mark in FY 2025
Income from operations increased to $3.4 million in FY 2025
SAN DIEGO--(BUSINESS WIRE)-- Womens health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the fourth quarter and year ended December 31, 2025. Highlights include:
Achieved record net sales... More